Aspire Biopharma Holdings Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| UBS GROUP AG | 01/29/2026 | 2.51 M | $331.96 K | 32,726.95% | 0.03% |
| CREWE ADVISORS LLC | 01/16/2026 | 813.43 K | $107.29 K | 0.00% | 0.01% |
| JANE STREET GROUP, LLC | 02/12/2026 | 688.14 K | $90.77 K | 2,252.06% | 0.01% |
| VANGUARD GROUP INC | 01/29/2026 | 428.55 K | $56.57 K | 0.00% | 0.01% |
| OPTIVISE ADVISORY SERVICES LLC | 01/12/2026 | 357.34 K | $47.13 K | 35.60% | 0.00% |
| XTX TOPCO LTD | 02/17/2026 | 265.47 K | $35.02 K | 853.18% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 247.56 K | $32.65 K | -1.04% | 0.00% |
| PROCYON ADVISORS, LLC | 01/07/2026 | 232.66 K | $30.69 K | -50.78% | 0.00% |
| ANTARA CAPITAL LP | 02/17/2026 | 202.90 K | $26.76 K | 0.00% | 0.00% |
| RESOLUTE ADVISORS LLC | 02/11/2026 | 155.83 K | $20.55 K | 88.23% | 0.00% |
| THREE SEASONS WEALTH, LLC | 01/15/2026 | 125.00 K | $16.49 K | 66.67% | 0.00% |
| VIRTU FINANCIAL LLC | 02/23/2026 | 108.79 K | $14.00 K | 100.00% | 0.00% |
| VR ADVISORY SERVICES LTD | 02/18/2026 | 97.39 K | $12.85 K | 0.00% | 0.00% |
| VERITION FUND MANAGEMENT LLC | 02/13/2026 | 97.39 K | $12.85 K | 100.00% | 0.00% |
| EP WEALTH ADVISORS, LLC | 02/18/2026 | 62.69 K | $8.27 K | 100.00% | 0.00% |
| P SCHOENFELD ASSET MANAGEMENT LP | 02/13/2026 | 58.56 K | $7.72 K | 0.00% | 0.00% |
| AVION WEALTH | 01/23/2026 | 54.11 K | $7.00 K | 0.00% | 0.00% |
| SCIENTECH RESEARCH LLC | 02/17/2026 | 51.60 K | $6.81 K | 100.00% | 0.00% |
| PERISCOPE CAPITAL INC. | 02/10/2026 | 50.00 K | $6.60 K | 0.00% | 0.00% |
| CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2026 | 49.13 K | $6.48 K | 0.00% | 0.00% |
| HALLMARK CAPITAL MANAGEMENT INC | 02/04/2026 | 40.00 K | $5.28 K | 0.00% | 0.00% |
| PLATFORM TECHNOLOGY PARTNERS | 02/13/2026 | 37.61 K | $4.96 K | 0.00% | 0.00% |
| CROSSINGBRIDGE ADVISORS, LLC | 02/13/2026 | 24.35 K | $3.21 K | 0.00% | 0.00% |
| STONEX GROUP INC. | 02/12/2026 | 14.68 K | $1.94 K | 100.00% | 0.00% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 14.24 K | $1.88 K | 100.00% | 0.00% |
| ALLRED CAPITAL MANAGEMENT, LLC | 02/10/2026 | 11.19 K | $1.48 K | 0.00% | 0.00% |
| FISHER ASSET MANAGEMENT, LLC | 02/09/2026 | 10.00 K | $1.32 K | 100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 9.61 K | $1.27 K | -69.12% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 282 | $37 | 11.46% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 100 | $13 | 0.00% | 0.00% |
| COLONY GROUP, LLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| SOA WEALTH ADVISORS, LLC. | 01/20/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aspire Biopharma Holdings Inc. institutional Ownership - FAQ's
During the previous two years, 32 institutional investors and hedge funds held shares of Aspire Biopharma Holdings Inc.. The most heavily invested institutionals were:
HALLMARK CAPITAL MANAGEMENT INC: 1,000
JANE STREET GROUP, LLC: 0
Resolute Advisors LLC: 0
Optivise Advisory Services LLC: 0
Procyon Advisors, LLC: 0
Avion Wealth: 0
0.09% of Aspire Biopharma Holdings Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.80 M shares in the last 24 months. This purchase volume represents approximately $2.17 M in transactions.